在患有败血症的患者中,HCT-ALB和医院死亡率之间的U形关联
Qian Liu1,2, Weilin Lu3, Siyi Zhou1,2
1Department of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
Scientific reports
|April 28, 2025
概括
血红素-血清白蛋白 (HCT-ALB) 差异预测了ICU患者的败血症死亡率. 一个U形曲线显示了6.1的临界值,风险在这个水平以上显著增加,特别是在老年人中.
科学领域:
- 关键护理医学 关键护理医学
- 临床化学 临床化学
- 流行病学 流行病学
背景情况:
- 血红素和血清白蛋白 (HCT-ALB) 的差异是传染病中的潜在生物标志物.
- 进入ICU的败血症患者中,HCT-ALB与死亡率之间的非线性关系尚不清楚.
研究的目的:
- 调查HCT-ALB差异与在重症监护室 (ICU) 诊断为败血症的患者的医院死亡率之间的非线性关联.
- 为了确定HCT-ALB毒症差异的潜在值效应和与年龄相关的预后影响.
主要方法:
- 一项回顾性多中心队列研究包括了7,546名患有败血症的ICU患者.
- 考克斯比例危险模型采用平滑曲线适配来分析HCT-ALB-死亡率关系.
- 进行了值分析,以确定协会中的拐点.
主要成果:
- 在HCT-ALB和死亡率之间观察到U形的关联,转折点在6.1.
- 低于6.1的HCT-ALB值显示出保护作用,而6.1或以上的值与死亡风险增加有关.
- 观察到与年龄的显著相互作用,表明老年患者 (≥65岁) 的死亡风险增加.
结论:
- HCT-ALB差异是ICU患者败血症结果的非线性预测指标.
- 该研究强调了HCT-ALB在败血症管理中的关键值动态和年龄相关的预后价值.
- 这些发现表明,HCT-ALB可能是毒症风险分层的一个有价值的工具.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Hazard Ratio
73
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
73
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76


